Successful treatment with ibrutinib therapy for refractory SLL/CLL with uncontrolled ascites

Shori Abe

Presentation information

Poster Session

Sat. Oct, 13

Poster Session 2-14 CLL: Case reports

Sat. Oct 13, 2018 5:30 PM - 6:10 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Sadao Aoki (Pathophysiology Division, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences.)

[PS2-14-3] Successful treatment with ibrutinib therapy for refractory SLL/CLL with uncontrolled ascites

Shori Abe^1,3, Jun Nomura^1,3, Masahiro Kobayashi³, Ryo Ichinohasama², Junichi Kameoka³ (1.Hematology, Thoku Medical and Pharmaceutical University., Wakabayashi Hospital, Japan, 2.Division of Hematopathology, Tohoku University Graduate, Japan., 3.Hematology and Rheumatology, Tohoku medical and Pharmaceutical University, Japan)

Abstract password authentication.
Password is written on a program and abstract book.